To include your compound in the COVID-19 Resource Center, submit it here.

FDA announces 2018 user fees

FDA released its FY2018 user fee rates for pharmaceuticals and biosimilars in accordance with PDUFA

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE